Skip to main content

Find Clinical Trials

Home
Conditions
Otorhinolaryngologic Diseases

Clinical trial condition

Otorhinolaryngologic Diseases

Explore clinical trials studying Otorhinolaryngologic Diseases. Study availability and eligibility vary by location and protocol.

5,428 public trials 861 recruiting studies

Refine in advanced search Browse all conditions

Otorhinolaryngologic Diseases trial results

Completed

Evaluation of Open-canal Behind-the-Ear Hearing Aids and Traditional In-the-ear Hearing Aids.

NCT00727909

Conditions: Ear Diseases, Hearing Disorders, Hearing Loss, +6 more
Locations: VA Medical Center, Bay Pines Bay Pines, Florida, United States

James H. Quillen VA Medical Center Mountain Home, Tennessee, United States

VA Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM

NCT02156791

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations: Universitätsklinikum Carl-Gustav-Carus, Dresden, Germany Dresden, Germany

View Trial Details

Completed

A Randomized Study of Temperature-controlled and Bipolar Radiofrequency for Inferior Turbinate Reduction

NCT01054521

Conditions: Airway Obstruction, Nasal Obstruction, Nose Diseases, +5 more
Locations: Siriraj Hospital Bangkok, Thailand

View Trial Details

Completed

Parotid-sparing IMRT for Nasopharyngeal Cancer

NCT02149641

Conditions: Head and Neck Neoplasms, Intensity Modulated Radiotherapy With Chemotherapy, Nasopharyngeal Cancers, +9 more
Locations: The Royal Marsden NHS Foundation Trust London, United Kingdom

View Trial Details

Completed

Cognitive Behavioral Therapy for Hyperacusis

NCT01321814

Conditions: Ear Diseases, Hearing Disorders, Hyperacusis, +6 more
Locations: Uppsala, Sweden

View Trial Details

Completed

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

NCT01506375

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations: Universitaire Ziekenhuis van Leuven Leuven, Belgium

View Trial Details

Completed

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

NCT01308021

Conditions: Grass Pollen Allergy, Hay Fever, Hypersensitivity, +9 more
Locations: CHR Saint Joseph Warquignies Boussu, Belgium

AZ Sint Lucas Bruges, Belgium

Clinique du Parc Léopold Brussels, Belgium

UZ Brussel Brussels, Belgium

View all 19 locations

View Trial Details

Completed

Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis

NCT01378429

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +9 more
Locations: West Coast Clinical Trials Costa Mesa, California, United States

Clinical Research Atlanta Stockbridge, Georgia, United States

Sneeze, Wheeze, & Itch Associates, LLC Normal, Illinois, United States

Clinical Research Institute Plymouth, Minnesota, United States

View Trial Details

Completed

A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus

NCT01378650

Conditions: Ear Diseases, Hearing Disorders, Nervous System Diseases, +6 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

NCT01087970

Conditions: Head and Neck Neoplasms, Laryngeal Diseases, Neoplasms, +3 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jonesboro, Arkansas, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Waterbury, Connecticut, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fort Myers, Florida, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States

View all 21 locations

View Trial Details